Literature DB >> 11559269

How do observational studies expand the evidence base for therapy?

M J Radford, J M Foody.   

Abstract

Mesh：

Year:  2001        PMID： 11559269     DOI： 10.1001/jama.286.10.1228

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  13 in total

Review 1.  Is the promise of randomized control trials ("evidence-based medicine") overstated?

Authors:  Louis R Caplan
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

Review 2.  The contribution of observational studies to the knowledge of drug effectiveness in heart failure.

Authors:  Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Eric van Sonderen; Olaf H Klungel; Robbert Sanderman; Adelita V Ranchor; Flora M Haaijer-Ruskamp
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

3.  Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Elizabeth L Yanik; Sonia Napravnik; Patrick Ryscavage; Susan L Koletar; Richard Moore; W Christopher Mathews; Heidi M Crane; Kenneth Mayer; Anne Zinski; James S Kahn; Joseph J Eron
Journal:  AIDS       Date:  2013-06-19       Impact factor: 4.177

4.  Provider treatment intensity and outcomes for patients with early-stage bladder cancer.

Authors:  Brent K Hollenbeck; Zaojun Ye; Rodney L Dunn; James E Montie; John D Birkmeyer
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

5.  Racial differences in treatment and outcomes among patients with early stage bladder cancer.

Authors:  Brent K Hollenbeck; Rodney L Dunn; Zaojun Ye; John M Hollingsworth; Cheryl T Lee; John D Birkmeyer
Journal:  Cancer       Date:  2010-01-01       Impact factor: 6.860

6.  Managing chronic disease: evidence-based medicine or patient centred medicine?

Authors:  Thea P M Vliet Vlieland
Journal:  Health Care Anal       Date:  2002

7.  Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction.

Authors:  JoAnne Micale Foody; Saif S Rathore; Deron Galusha; Frederick A Masoudi; Edward P Havranek; Martha J Radford; Harlan M Krumholz
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

8.  Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study.

Authors:  Jeffrey S Berger; David L Brown; Gregory L Burke; Albert Oberman; John B Kostis; Robert D Langer; Nathan D Wong; Sylvia Wassertheil-Smoller
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-03-05

Review 9.  Reassessing the evidence hierarchy in asthma: evaluating comparative effectiveness.

Authors:  David Price; Alison Chisholm; Thys van der Molen; Nicolas Roche; Elizabeth V Hillyer; Jean Bousquet
Journal:  Curr Allergy Asthma Rep       Date:  2011-12       Impact factor: 4.806

Review 10.  beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.

Authors:  Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
Journal:  Drugs Aging       Date:  2007       Impact factor: 4.271
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.